About This Project
Oxidized forms of the peptide beta-amyloid (Aβ) are considered to be toxic to the brain, leading to the development of Alzheimer's disease (AD). Based on our preliminary data, we hypothesize that an immunization of an AD-model mice with a recombinant protein enriched with the oxidized amino acid methionine sulfoxide will cause the removal of toxic Aβ from brain. Consequently, this treatment is expected to inhibit the development of AD and alleviate cognitive impairment.
Recent Lab Notes From This Project
Browse Other Projects on Experiment
Are American Women of Childbearing Age Changing Their Behaviors in Response to the Zika Virus Outbreak?
The Zika virus outbreak is an international public health emergency, and is linked to microcephaly and...